STAT3 and metabolic disease: Similarly, in metabolic diseases, such as nonalcoholic fatty liver disease, STAT3 has been implicated in immune cell infiltration and inflammatory regulation through modulation of the GCSFR-SOCS3-JAK-STAT3 signaling pathway [40].